ResMed

RMDleader

ResMed is the global leader in cloud-connected devices and software for sleep apnea and respiratory care. It has benefited significantly from competitor Philips' CPAP recall, gaining substantial market share.

⇄ Compare

Produkte & Umsatz

Umsatzanteil nach Produkt

Umsatzaufschlüsselung ($4.7B)

Statische Daten (Echtzeitfinanzen werden geladen…)

Devices (50%)

Masks & Accessories (30%)

Software as a Service (20%)

Segmentzusammensetzung und Hauptkunden

Produktdetails

CPAP/BiPAP Devices50%

Flow generators for treating obstructive sleep apnea and respiratory insufficiency

Masks & Accessories30%

Nasal, full-face, and pillow masks for sleep therapy

SaaS Solutions20%

Cloud-based patient engagement and out-of-hospital care management software

Lieferkettenbeziehungen

Wettbewerber

Medtronic

Respiratory therapy devices (legacy)

Auswirkung: Competitor in respiratory

Wichtige Kunden

UnitedHealth Group

CPAP coverage for insured members

Auswirkung: $300M+ annually

Makro- und Marktkontext

헬스케어Sektornachrichten

메디케어 수가 압박 vs AI 진단 효율화 — 선별적 접근 필요

미국 헬스케어 지출 (2026E)

$4.8T

AI 진단 정확도 개선

+23% vs 기존

UNH 의료손해율

87.3%

약가 협상 대상 의약품

20종 (IRA)

Nächste Katalysatoren

◆CMS 메디케어 최종 수가 발표 (2026.Q2)◆UNH/HUM/CVS Q1 실적 (2026.04)◆IRA 약가 협상 2차 품목 공개

Aktuelle Nachrichten

Nachrichten laden...

KI-Analyse

Klicken Sie auf "KI-Analyse abrufen" für eine KI-gestützte Lieferkettenanalyse von ResMed.

Unternehmensinformationen

Hauptsitz

San Diego, California, USA

Gegründet

1989

Mitarbeiter

10,000+

Website

resmed.com

Sektorübersicht — 헬스케어

Sektornachrichten